Prescription ID | TCMF6845 |
Pinyin Name | Yang Xin An Shen Wan |
Chinese Name | 养心安神丸 |
English Name | Yang Xin An Shen Pills |
Function Description | 不寐, 眩晕, 心悸, 耳鸣, 健忘 |
Indications | Tinnitus disorder, Vertigo disorder, Forgetfulness disorder, Insomnia disorder, Insomnia, Tinnitus, Palpitations, Dizziness |
Disease ICD-11 Category |
SC75 [Tinnitus disorder (TM1), 耳鸣 (TM1)
]; SD22 [Vertigo disorder (TM1), 眩晕 (TM1) ]; SD23 [Forgetfulness disorder (TM1), 健忘 (TM1) ]; SD84 [Insomnia disorder (TM1), 不寐 (TM1) ]; 7A0Z [Insomnia disorders, unspecified, 失眠障碍,未特指的 ]; MC41 [Tinnitus, 耳鸣 ]; MC81.2 [Palpitations, 心悸 ]; MB48 [Dizziness and giddiness, 头晕和眩晕 ]; |
Human Tissues Associated with Indication | Heart, Brain |
Reference | CFDA |
Reference Book/link | http://samr.cfda.gov.cn/WS01/CL0001/ |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH2202 | Schisandra chinensis | 五味子 | TCMH2202 | ITSAM2867-14 |
TCMH1963 | Caulis polygoni multiflori | 首乌藤 | TCMH1963 | |
TCMH815 | Flos albiziae | 合欢花 | TCMH815 | |
TCMH967 | Polygonatum sibiricum | 黄精 | TCMH967 | ITSAH4762-14 |
TCMH421 | Angelica sinensis | 当归 | TCMH421 | ITSAF173-14 |
TCMH407 | Salvia miltiorrhiza | 丹参 | TCMH407 | ITSAH2408-14 |
TCMH2052 | Ziziphus jujuba var. spinosa | 酸枣仁 | TCMH2052 | ITSAM943-14 |
TCMH2554 | Polygala tenuifolia | 远志 | TCMH2554 | MF096619 |
TCMH2624 | Anemarrhena asphodeloides | 知母 | TCMH2624 | GBVA3255-11, GBVU1201-13 |
TCMH324 | Magnetitum | 磁石 | TCMH324 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT100 | TTR | Transthyretin | Unclassified | P02766 |
TCMT101 | PTPN1 | Protein-tyrosine phosphatase 1B | Hydrolase | P18031 |
TCMT102 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | Hydrolase | P24666 |
TCMT103 | PTPRF | Receptor-type tyrosine-protein phosphatase F (LAR) | Hydrolase | P10586 |
TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
TCMT126 | TERT | Telomerase reverse transcriptase | Transferase | O14746 |
TCMT127 | PARP1 | Poly [ADP-ribose] polymerase-1 | Transferase | P09874 |
TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
TCMT139 | CA6 | Carbonic anhydrase VI | Lyase | P23280 |
TCMT140 | CA5B | Carbonic anhydrase VB | Lyase | Q9Y2D0 |
TCMT141 | CA5A | Carbonic anhydrase VA | Lyase | P35218 |
TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
TCMT150 | RORC | Nuclear receptor ROR-gamma | Nuclear receptor | P51449 |
TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
TCMT159 | TYR | Tyrosinase | Oxidoreductase | P14679 |
TCMT161 | HCAR2 | Hydroxycarboxylic acid receptor 2 | GPCR | Q8TDS4 |
TCMT171 | PTPN6 | Protein-tyrosine phosphatase 1C | Hydrolase | P29350 |
TCMT174 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | Oxidoreductase | P28845 |
TCMT186 | MAOB | Monoamine oxidase B | Oxidoreductase | P27338 |
TCMT190 | PTPN2 | T-cell protein-tyrosine phosphatase | Hydrolase | P17706 |
TCMT206 | CYP2A6 | Cytochrome P450 2A6 | Oxidoreductase | P11509 |
TCMT210 | CES2 | Carboxylesterase 2 | Hydrolase | O00748 |
TCMT211 | CES1 | Acyl coenzyme A:cholesterol acyltransferase | Transferase | P23141 |
TCMT212 | SRC | Tyrosine-protein kinase SRC | Kinase | P12931 |
TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
TCMT217 | CYP2C8 | Cytochrome P450 2C8 | Oxidoreductase | P10632 |
TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
TCMT233 | PTPN11 | Protein-tyrosine phosphatase 2C | Hydrolase | Q06124 |
TCMT236 | ESR2 | Estrogen receptor beta | Nuclear receptor | Q92731 |
TCMT239 | PIM1 | Serine/threonine-protein kinase PIM1 | Kinase | P11309 |
TCMT247 | ADRA2A | Alpha-2a adrenergic receptor | GPCR | P08913 |
TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
TCMT260 | FLT3 | Tyrosine-protein kinase receptor FLT3 | Kinase | P36888 |
TCMT261 | DAPK1 | Death-associated protein kinase 1 | Kinase | P53355 |
TCMT268 | CYP2A13 | Cytochrome P450 2A13 | Oxidoreductase | Q16696 |
TCMT280 | AKR1B10 | Aldo-keto reductase family 1 member B10 | Oxidoreductase | O60218 |
TCMT295 | MMP1 | Matrix metalloproteinase-1 | Hydrolase | P03956 |
TCMT296 | ADORA1 | Adenosine A1 receptor | GPCR | P30542 |
TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
TCMT298 | FABP3 | Fatty acid binding protein muscle | Hydrolase | P05413 |
TCMT3 | ALOX15 | Arachidonate 15-lipoxygenase | Oxidoreductase | P16050 |
TCMT302 | HMGCR | HMG-CoA reductase | Oxidoreductase | P04035 |
TCMT306 | MMP2 | Matrix metalloproteinase-2 | Hydrolase | P08253 |
TCMT307 | KCNH2 | HERG | Ion channel | Q12809 |
TCMT31 | CYP2C19 | Cytochrome P450 2C19 | Oxidoreductase | P33261 |
TCMT321 | MMP9 | Matrix metalloproteinase 9 | Hydrolase | P14780 |
TCMT322 | MMP13 | Matrix metalloproteinase 13 | Hydrolase | P45452 |
TCMT327 | TRPV1 | Vanilloid receptor | Ion channel | Q8NER1 |
TCMT33 | CYP3A4 | Cytochrome P450 3A4 | Oxidoreductase | P08684 |
TCMT344 | AOX1 | Aldehyde oxidase | Oxidoreductase | Q06278 |
TCMT359 | FYN | Tyrosine-protein kinase FYN | Kinase | P06241 |
TCMT369 | IGF1R | Insulin-like growth factor I receptor | Kinase | P08069 |
TCMT370 | KDR | Vascular endothelial growth factor receptor 2 | Kinase | P35968 |
TCMT374 | AURKB | Serine/threonine-protein kinase Aurora-B | Kinase | Q96GD4 |
TCMT388 | AXL | Tyrosine-protein kinase receptor UFO | Kinase | P30530 |
TCMT39 | PDE5A | Phosphodiesterase 5A | Hydrolase | O76074 |
TCMT401 | MET | Hepatocyte growth factor receptor | Kinase | P08581 |
TCMT422 | CAMK2B | CaM kinase II beta | Kinase | Q13554 |
TCMT445 | NEK2 | Serine/threonine-protein kinase NEK2 | Kinase | P51955 |
TCMT462 | NEK6 | Serine/threonine-protein kinase NEK6 | Kinase | Q9HC98 |
TCMT479 | AKT1 | Serine/threonine-protein kinase AKT | Kinase | P31749 |
TCMT484 | PLK1 | Serine/threonine-protein kinase PLK1 | Kinase | P53350 |
TCMT563 | CDC25B | Dual specificity phosphatase Cdc25B | Hydrolase | P30305 |
TCMT591 | ESRRA | Estrogen-related receptor alpha | Nuclear receptor | P11474 |
TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
TCMT597 | SLC28A3 | Solute carrier family 28 member 3 | Transporter | Q9HAS3 |
TCMT613 | NR3C1 | Glucocorticoid receptor | Nuclear receptor | P04150 |
TCMT614 | EGLN1 | Egl nine homolog 1 | Oxidoreductase | Q9GZT9 |
TCMT63 | PPARA | Peroxisome proliferator-activated receptor alpha | Nuclear receptor | Q07869 |
TCMT633 | SLC6A4 | Serotonin transporter | Transporter | P31645 |
TCMT634 | SLC6A2 | Norepinephrine transporter | Transporter | P23975 |
TCMT637 | SIRT3 | NAD-dependent deacetylase sirtuin 3 | Hydrolase | Q9NTG7 |
TCMT638 | SIRT2 | NAD-dependent deacetylase sirtuin 2 | Hydrolase | Q8IXJ6 |
TCMT66 | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | Oxidoreductase | P37059 |
TCMT690 | HDAC3 | Histone deacetylase 3 | Hydrolase | O15379 |
TCMT709 | SLC28A2 | Sodium/nucleoside cotransporter 2 | Transporter | O43868 |
TCMT710 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Transporter | O00337 |
TCMT734 | MMP12 | Matrix metalloproteinase 12 | Hydrolase | P39900 |
TCMT771 | ATR | Serine-protein kinase ATR | Kinase | Q13535 |
TCMT784 | AVPR2 | Vasopressin V2 receptor | GPCR | P30518 |
TCMT785 | CXCR1 | Interleukin-8 receptor A | GPCR | P25024 |
TCMT786 | CCR4 | C-C chemokine receptor type 4 | GPCR | P51679 |
TCMT791 | PKN1 | Protein kinase N1 | Kinase | Q16512 |
TCMT793 | PYGL | Liver glycogen phosphorylase | Transferase | P06737 |
TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
TCMT81 | ALOX12 | Arachidonate 12-lipoxygenase | Oxidoreductase | P18054 |
TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
TCMT82 | ESR1 | Estrogen receptor alpha | Nuclear receptor | P03372 |
TCMT83 | CD38 | Lymphocyte differentiation antigen CD38 | Unclassified | P28907 |
TCMT910 | ESRRB | Estrogen-related receptor beta | Nuclear receptor | O95718 |
Target ID | Target Name |
---|---|
TCMT1168 | Trichomonas vaginalis |
TCMT1175 | Human immunodeficiency virus |
TCMT1176 | Streptococcus pneumoniae |
TCMT1178 | Actinomyces viscosus |
TCMT1179 | Escherichia coli ATCC 8739 |
TCMT1180 | Human herpesvirus 2 |
TCMT1181 | Mycobacterium tuberculosis H37Ra |
TCMT1189 | Pseudomonas fluorescens |
TCMT1190 | Plasmodium falciparum (isolate FcB1 / Columbia) |
TCMT1208 | Escherichia coli K12 |
TCMT1209 | Staphylococcus haemolyticus |
TCMT1212 | Verticillium dahliae |
TCMT1213 | Neisseria gonorrhoeae |
TCMT1215 | Pseudomonas aeruginosa PAO1 |
TCMT1218 | Staphylococcus aureus |
TCMT1222 | Plasmodium falciparum D6 |
TCMT1223 | Staphylococcus epidermidis |
TCMT1226 | Klebsiella pneumoniae |
TCMT1229 | Enterococcus faecalis |
TCMT1231 | Human herpesvirus 1 strain KOS |
TCMT1232 | Pseudomonas aeruginosa |
TCMT1243 | Aspergillus flavus |
TCMT1245 | Phytophthora cactorum |
TCMT1246 | Escherichia coli |
TCMT1247 | Human herpesvirus 1 |
TCMT1248 | Hepatitis C virus |
TCMT1250 | Vesicular stomatitis virus |
TCMT1251 | Candida albicans |
TCMT1253 | Penicillium chrysogenum |
TCMT1255 | Human immunodeficiency virus 1 |
TCMT1282 | Colletotrichum orbiculare |
TCMT1284 | Penicillium expansum |
TCMT1286 | Bacillus cereus |
TCMT1294 | Human parainfluenza virus 3 |
TCMT1346 | Helicobacter pylori |
TCMT1349 | Helicobacter pylori SS1 |
TCMT1361 | Neisseria meningitidis |
TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
TCMT1393 | Vibrio sp. |
TCMT1405 | Penicillium citrinum |
TCMT1408 | Colletotrichum gloeosporioides |
TCMT1412 | Salmonella typhimurium |
TCMT1438 | Plasmodium falciparum |
TCMT1439 | Mycobacterium smegmatis |
TCMT1442 | Leishmania donovani |
TCMT1443 | Leishmania amazonensis |
TCMT1444 | Fusarium oxysporum |
TCMT1447 | Respiratory syncytial virus |
TCMT1448 | Enterobacter aerogenes |
TCMT1449 | Influenza A virus |
TCMT1450 | Plasmodium falciparum 3D7 |
TCMT1454 | Bacillus subtilis |
TCMT1455 | Mycobacterium tuberculosis H37Rv |
TCMT1458 | Filobasidiella neoformans |
TCMT1462 | Streptococcus mutans |
TCMT1463 | Mycobacterium tuberculosis |
TCMT1464 | Hepatitis B virus |
TCMT1465 | Entamoeba histolytica |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0044281 | small molecule metabolic process | AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, FABP3, HMGCR, PDE5A, PIM1, PPARA, TYR, XDH | 12.4537 |
[BP] GO:0015701 | bicarbonate transport | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 11.9795 |
[BP] GO:0006730 | one-carbon metabolic process | CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 11.0089 |
[BP] GO:0006629 | lipid metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, ESR1, FABP3, FABP4, HMGCR, HSD11B1, HSD17B2, MET, PPARA, TRPV1 | 10.8136 |
[BP] GO:0008202 | steroid metabolic process | AKR1B1, AKR1B10, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, ESR1, HMGCR, HSD11B1, HSD17B2 | 9.84125 |
[BP] GO:0008152 | metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HMGCR, HSD11B1, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TRPV1, TYR, XDH | 9.40465 |
[BP] GO:0033559 | unsaturated fatty acid metabolic process | ALOX12, ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 | 8.89178 |
[BP] GO:0042221 | response to chemical | ADRA2A, AKR1B1, ALOX15, AXL, CA2, CA9, CES1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HMGCR, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MMP2, MMP9, NR3C1, PPARA, RORC, SLC6A2, SLC6A4, SRC, TERT, TRPV1, TYR | 8.62849 |
[BP] GO:0006690 | icosanoid metabolic process | ALOX12, ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 | 8.62849 |
[BP] GO:0019748 | secondary metabolic process | AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR | 8.17244 |
[BP] GO:0055114 | oxidation-reduction process | AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, HMGCR, HSD11B1, HSD17B2, MAOB, TYR, XDH | 8.03952 |
[BP] GO:0019369 | arachidonic acid metabolic process | ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 | 8.00046 |
[BP] GO:0006631 | fatty acid metabolic process | ALOX12, ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, PPARA | 7.76908 |
[BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 | 7.27573 |
[BP] GO:0010033 | response to organic substance | ADRA2A, AKR1B1, ALOX15, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HMGCR, HSD17B2, IGF1R, KDR, MAOB, MMP2, NR3C1, PPARA, RORC, SLC6A4, SRC, TRPV1, TYR | 7.1357 |
[BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, AXL, CA9, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, HMGCR, HSD17B2, IGF1R, MAOB, MMP2, MMP9, NR3C1, PPARA, RORC, SLC6A4, SRC, TRPV1, TYR | 7.08225 |
[BP] GO:0048522 | positive regulation of cellular process | ACHE, ADORA1, ADRA2A, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CA2, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, HCAR2, HMGCR, IGF1R, KCNH2, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TRPV1, XDH | 7.08225 |
[BP] GO:1901568 | fatty acid derivative metabolic process | ALOX12, ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 | 7.08225 |
[BP] GO:0044237 | cellular metabolic process | ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HMGCR, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MET, MMP1, MMP2, NR3C1, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TYR, XDH | 7.02467 |
[BP] GO:0006805 | xenobiotic metabolic process | CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP3A4, RORC | 6.96018 |
[BP] GO:0065008 | regulation of biological quality | ACHE, ADORA1, ADRA2A, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, FABP3, FABP4, FLT3, HCAR2, HMGCR, HSD11B1, HSD17B2, KCNH2, KDR, MAOB, MET, PPARA, SLC6A2, SLC6A4, SRC, TERT, TRPV1, XDH | 6.83023 |
[BP] GO:0044255 | cellular lipid metabolic process | ACHE, AKR1B10, ALOX12, ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, FABP3, FABP4, HMGCR, MET, PPARA | 6.74859 |
[BP] GO:0015711 | organic anion transport | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, TRPV1 | 6.14854 |
[BP] GO:0048518 | positive regulation of biological process | ACHE, ADORA1, ADRA2A, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CA2, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HCAR2, HMGCR, IGF1R, KCNH2, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TRPV1, XDH | 6.10614 |
[BP] GO:0001676 | long-chain fatty acid metabolic process | ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 | 6.07443 |
[BP] GO:0033993 | response to lipid | AXL, CA2, CA9, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD17B2, MAOB, NR3C1, RORC, SLC6A4, SRC, TYR | 6.05991 |
[BP] GO:0042127 | regulation of cell proliferation | ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX12, CDC25B, CYP1B1, ESR1, ESRRA, FABP3, FLT3, HMGCR, IGF1R, KDR, MMP12, MMP2, MMP9, PDE5A, PIM1, SLC6A4, SRC, TERT, XDH | 6.05808 |
[BP] GO:0010035 | response to inorganic substance | AKR1B1, ALOX15, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MAOB, MMP9, SRC, TERT | 5.6986 |
[BP] GO:0009725 | response to hormone | ADRA2A, AKR1B1, CA2, CA9, CYP1A2, ESR1, ESRRA, FABP3, FLT3, MAOB, NR3C1, PPARA, SLC6A4, SRC, TRPV1 | 5.6986 |
[BP] GO:0032787 | None | ALOX12, ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, PPARA | 5.52192 |
[BP] GO:0030522 | intracellular receptor signaling pathway | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PIM1, PPARA, RORC, SRC | 5.48599 |
[BP] GO:0070887 | cellular response to chemical stimulus | ADRA2A, AKR1B1, ALOX15, AXL, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, MMP2, MMP9, NR3C1, RORC, SLC6A4, SRC, TERT, TRPV1 | 5.34413 |
[BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD17B2 | 5.29688 |
[BP] GO:0032501 | multicellular organismal process | ADORA1, ADRA2A, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AXL, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, FABP4, HMGCR, HSD17B2, IGF1R, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, RORC, SLC6A2, SLC6A4, SRC, TRPV1, TYR | 5.29688 |
[BP] GO:1901615 | organic hydroxy compound metabolic process | AKR1B1, AKR1B10, ALOX12, ALOX15, CES1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HMGCR, MAOB, TYR | 5.27861 |
[BP] GO:0043401 | steroid hormone mediated signaling pathway | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC, SRC | 5.27861 |
[BP] GO:0010817 | regulation of hormone levels | ACHE, ADORA1, ADRA2A, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HCAR2, HMGCR, HSD11B1, HSD17B2 | 5.2718 |
[BP] GO:0014070 | response to organic cyclic compound | CA2, CA9, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, MAOB, NR3C1, RORC, SLC6A4, SRC, TRPV1, TYR | 5.23695 |
[BP] GO:0009056 | catabolic process | ACHE, ADORA1, AKR1B10, AOX1, AURKB, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, FABP3, FABP4, MAOB, MMP1, MMP12, MMP2, MMP9, PDE5A, SRC, XDH | 5.23695 |
[BP] GO:0042493 | response to drug | AKR1B1, AXL, CA9, CYP1A1, CYP1B1, FABP3, HMGCR, KCNH2, KDR, MAOB, NR3C1, SLC6A2, SLC6A4, SRC, TRPV1 | 5.1715 |
[BP] GO:0009719 | response to endogenous stimulus | ADRA2A, AKR1B1, CA2, CA9, CYP1A2, ESR1, ESRRA, FABP3, FLT3, IGF1R, MAOB, MMP2, NR3C1, PPARA, SLC6A4, SRC, TRPV1 | 5.13359 |
[BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1, CYP2C19 | 5.07815 |
[BP] GO:0006820 | anion transport | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, TRPV1 | 4.98378 |
[BP] GO:0042738 | exogenous drug catabolic process | CYP1A2, CYP2A6, CYP2C19, CYP3A4 | 4.72077 |
[BP] GO:0010941 | regulation of cell death | ADORA1, AKR1B1, ALOX12, AURKB, AXL, CYP1B1, ESR1, FLT3, HCAR2, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT, TRPV1, XDH | 4.71331 |
[BP] GO:0010647 | positive regulation of cell communication | ADORA1, ADRA2A, AKR1B1, ALOX15, AXL, CA2, CA7, CYP19A1, CYP1B1, FLT3, HCAR2, HMGCR, KDR, MET, MMP12, MMP9, PDE5A, PTPN1, SRC, TERT, XDH | 4.68775 |
[BP] GO:0023056 | positive regulation of signaling | ADORA1, ADRA2A, AKR1B1, ALOX15, AXL, CA2, CA7, CYP19A1, CYP1B1, FLT3, HCAR2, HMGCR, KDR, MET, MMP12, MMP9, PDE5A, PTPN1, SRC, TERT, XDH | 4.66228 |
[BP] GO:1901617 | organic hydroxy compound biosynthetic process | AKR1B1, ALOX12, ALOX15, CES1, CYP19A1, CYP3A4, HMGCR, TYR | 4.63201 |
[BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B2 | 4.61048 |
[BP] GO:0043067 | regulation of programmed cell death | ADORA1, AKR1B1, ALOX12, AURKB, AXL, CYP1B1, ESR1, FLT3, HCAR2, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, TERT, TRPV1, XDH | 4.57205 |
[BP] GO:0009755 | hormone-mediated signaling pathway | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC, SRC | 4.54848 |
[BP] GO:0050896 | response to stimulus | ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, CA2, CA6, CA9, CES1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HMGCR, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MMP12, MMP2, MMP9, NR3C1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TRPV1, TYR | 4.54848 |
[BP] GO:0019752 | carboxylic acid metabolic process | ALOX12, ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, PIM1, PPARA, TYR | 4.36624 |
[BP] GO:0032879 | regulation of localization | ACHE, ADORA1, ADORA3, ADRA2A, ALOX12, ALOX15, AXL, CA2, CA7, CYP19A1, CYP1B1, HCAR2, HMGCR, IGF1R, KCNH2, KDR, MAOB, MET, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC, TERT, TRPV1 | 4.28571 |
[BP] GO:0006720 | isoprenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, HMGCR | 4.20777 |
[BP] GO:0006694 | steroid biosynthetic process | AKR1B1, CES1, CYP19A1, CYP3A4, HMGCR, HSD11B1, HSD17B2 | 4.1895 |
[BP] GO:0048523 | negative regulation of cellular process | ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX12, AURKB, AXL, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HMGCR, IGF1R, KCNH2, KDR, MAOB, MET, MMP12, MMP9, NR3C1, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TRPV1, XDH | 4.16277 |
[BP] GO:0048519 | negative regulation of biological process | ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HCAR2, HMGCR, IGF1R, KCNH2, KDR, MAOB, MET, MMP12, MMP9, NR3C1, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TRPV1, XDH | 4.11481 |
[BP] GO:0019216 | regulation of lipid metabolic process | ADORA1, ADRA2A, CYP1A1, FABP3, FLT3, HCAR2, HMGCR, PPARA, RORC, SRC | 3.99448 |
[BP] GO:0042981 | regulation of apoptotic process | ADORA1, AKR1B1, ALOX12, AURKB, AXL, CYP1B1, ESR1, FLT3, HCAR2, HMGCR, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TERT, TRPV1, XDH | 3.99448 |
[BP] GO:0071310 | cellular response to organic substance | ADRA2A, AKR1B1, ALOX15, AXL, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, NR3C1, RORC, SLC6A4, SRC, TRPV1 | 3.92981 |
[BP] GO:0043436 | oxoacid metabolic process | ALOX12, ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, PIM1, PPARA, TYR | 3.87594 |
[BP] GO:0060548 | negative regulation of cell death | ADORA1, AKR1B1, ALOX12, AURKB, AXL, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT | 3.86341 |
[BP] GO:0006082 | organic acid metabolic process | ALOX12, ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, PIM1, PPARA, TYR | 3.78818 |
[BP] GO:2001300 | lipoxin metabolic process | ALOX12, ALOX15, ALOX5 | 3.7577 |
[BP] GO:0016098 | monoterpenoid metabolic process | CYP1A2, CYP2C19, CYP3A4 | 3.7577 |
[BP] GO:0051716 | cellular response to stimulus | ADRA2A, AKR1B1, ALOX15, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, MMP2, MMP9, NR3C1, PTPN1, RORC, SLC6A4, SRC, TERT, TRPV1 | 3.7577 |
[BP] GO:0031325 | positive regulation of cellular metabolic process | ADORA1, ADRA2A, ALOX15, AURKB, CDC25B, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, HMGCR, IGF1R, KDR, MAOB, MET, MMP12, MMP9, NR3C1, PDE5A, PPARA, PTPN1, RORC, SRC, TERT, TRPV1, XDH | 3.70939 |
[BP] GO:0009636 | response to toxic substance | AKR1B1, AXL, CES1, CYP1A1, CYP1B1, HMGCR, KDR, MAOB, SLC6A4, SRC | 3.64111 |
[BP] GO:0009893 | positive regulation of metabolic process | ADORA1, ADRA2A, ALOX15, AURKB, CDC25B, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, HMGCR, IGF1R, KDR, MAOB, MET, MMP12, MMP9, NR3C1, PDE5A, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TRPV1, XDH | 3.60677 |
[BP] GO:0043069 | negative regulation of programmed cell death | ADORA1, AKR1B1, ALOX12, AURKB, AXL, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, TERT | 3.60677 |
[BP] GO:0006367 | transcription initiation from RNA polymerase II promoter | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC | 3.57844 |
[BP] GO:1903409 | reactive oxygen species biosynthetic process | CYP1A1, CYP1A2, CYP1B1, MAOB | 3.56787 |
[BP] GO:0044238 | primary metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, AURKB, AXL, CDC25B, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HMGCR, HSD11B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PDE5A, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TRPV1, TYR, XDH | 3.56625 |
[BP] GO:0009698 | phenylpropanoid metabolic process | CYP1A1, CYP2A13, CYP2A6 | 3.55831 |
[BP] GO:0009804 | coumarin metabolic process | CYP1A1, CYP2A13, CYP2A6 | 3.55831 |
[BP] GO:0008284 | positive regulation of cell proliferation | ADRA2A, AKR1B1, ALOX12, CDC25B, ESR1, FLT3, HMGCR, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, TERT | 3.53886 |
[BP] GO:0071704 | organic substance metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, AURKB, AXL, CDC25B, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HMGCR, HSD11B1, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PDE5A, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TRPV1, TYR, XDH | 3.51331 |
[BP] GO:0051173 | positive regulation of nitrogen compound metabolic process | ADORA1, ADRA2A, ALOX15, AURKB, CDC25B, ESR1, ESR2, ESRRA, ESRRB, FLT3, HMGCR, IGF1R, KDR, MAOB, MET, MMP12, MMP9, NR3C1, PDE5A, PPARA, PTPN1, RORC, SRC, TERT, TRPV1, XDH | 3.49986 |
[BP] GO:0017144 | drug metabolic process | ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, MAOB | 3.49628 |
[BP] GO:0006721 | terpenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4 | 3.45883 |
[BP] GO:0048513 | animal organ development | ACHE, AXL, CA2, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, PPARA, SRC, TYR | 3.45267 |
[BP] GO:0042446 | hormone biosynthetic process | AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B2 | 3.39984 |
[BP] GO:0050665 | hydrogen peroxide biosynthetic process | CYP1A1, CYP1A2, MAOB | 3.3913 |
[BP] GO:0042592 | homeostatic process | ADORA1, ADRA2A, AKR1B1, ALOX12, AXL, CA12, CA2, CA7, ESR1, FABP3, FABP4, FLT3, KCNH2, MET, SRC, TERT, TRPV1 | 3.3753 |
[BP] GO:0051049 | regulation of transport | ACHE, ADORA1, ADRA2A, ALOX15, AXL, CA2, CA7, CYP19A1, HCAR2, HMGCR, KCNH2, MAOB, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC, TERT, TRPV1 | 3.37462 |
[BP] GO:0008610 | lipid biosynthetic process | ACHE, AKR1B1, ALOX12, ALOX15, CES1, CYP19A1, CYP1A1, CYP3A4, HMGCR, HSD11B1, HSD17B2 | 3.34047 |
[BP] GO:0042737 | drug catabolic process | ACHE, CYP1A2, CYP2A6, CYP2C19, CYP3A4, MAOB | 3.33605 |
[BP] GO:0071407 | cellular response to organic cyclic compound | CYP1A1, CYP1B1, ESR1, FLT3, NR3C1, RORC, SLC6A4, SRC, TRPV1 | 3.27887 |
[BP] GO:0016042 | lipid catabolic process | ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 | 3.18223 |
[BP] GO:0032502 | developmental process | ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, CA2, CA9, CDC25B, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FABP4, FLT3, HMGCR, HSD11B1, HSD17B2, KDR, MAOB, MET, MMP2, MMP9, PIM1, PPARA, RORC, SLC6A4, SRC, TERT, TYR | 3.11772 |
[BP] GO:1902533 | positive regulation of intracellular signal transduction | ADORA1, ADRA2A, AKR1B1, ALOX15, AXL, CYP1B1, FLT3, HMGCR, KDR, MET, PDE5A, PTPN1, SRC, XDH | 3.11772 |
[BP] GO:0032844 | regulation of homeostatic process | ADORA1, ADRA2A, AURKB, CA2, CA7, HCAR2, HMGCR, KDR, SRC, TRPV1 | 3.11043 |
[BP] GO:0035690 | cellular response to drug | AKR1B1, AXL, CYP1B1, KCNH2, KDR, NR3C1, SRC, TRPV1 | 3.06369 |
[BP] GO:0043066 | negative regulation of apoptotic process | ADORA1, AKR1B1, ALOX12, AURKB, AXL, HMGCR, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TERT | 3.04402 |
[BP] GO:0006811 | None | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, KCNH2, PPARA, SLC6A2, SLC6A4, TRPV1 | 3.01394 |
[BP] GO:0048661 | positive regulation of smooth muscle cell proliferation | AKR1B1, HMGCR, MMP2, MMP9, TERT | 3.00274 |
[BP] GO:0006352 | DNA-templated transcription, initiation | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC | 2.99485 |
[BP] GO:0048585 | negative regulation of response to stimulus | ADORA1, ADRA2A, ALOX12, ALOX15, CYP19A1, ESR1, ESR2, HMGCR, IGF1R, MET, MMP12, MMP9, PPARA, PTPN1, SRC, TERT, XDH | 2.93126 |
[BP] GO:1901701 | cellular response to oxygen-containing compound | AKR1B1, AXL, CYP1B1, ESR1, IGF1R, MMP2, MMP9, NR3C1, RORC, SLC6A4, SRC, TRPV1 | 2.88603 |
[BP] GO:0043410 | positive regulation of MAPK cascade | ADORA1, ADRA2A, ALOX15, FLT3, HMGCR, KDR, PDE5A, PTPN1, SRC, XDH | 2.87117 |
[BP] GO:0009967 | positive regulation of signal transduction | ADORA1, ADRA2A, AKR1B1, ALOX15, AXL, CYP1B1, FLT3, HMGCR, KDR, MET, MMP12, MMP9, PDE5A, PTPN1, SRC, TERT, XDH | 2.83667 |
[BP] GO:0010646 | regulation of cell communication | ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CYP19A1, CYP1B1, ESR1, ESR2, FLT3, HCAR2, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PDE5A, PTPN1, SLC6A4, SRC, TERT, XDH | 2.82517 |
[BP] GO:0030334 | regulation of cell migration | ADORA1, ADORA3, ADRA2A, ALOX12, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, SRC, TERT | 2.7898 |
[BP] GO:0023051 | regulation of signaling | ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CYP19A1, CYP1B1, ESR1, ESR2, FLT3, HCAR2, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PDE5A, PTPN1, SLC6A4, SRC, TERT, XDH | 2.78037 |
[BP] GO:0051240 | positive regulation of multicellular organismal process | ADRA2A, ALOX12, AXL, CA2, CYP1B1, ESRRB, HCAR2, HMGCR, KDR, MET, MMP12, MMP9, PDE5A, PIM1, SRC, TERT, TRPV1 | 2.78037 |
[BP] GO:0009115 | None | AOX1, XDH | 2.78037 |
[BP] GO:2001301 | lipoxin biosynthetic process | ALOX12, ALOX15 | 2.78037 |
[BP] GO:2001302 | lipoxin A4 metabolic process | ALOX12, ALOX15 | 2.78037 |
[BP] GO:2001303 | lipoxin A4 biosynthetic process | ALOX12, ALOX15 | 2.78037 |
[BP] GO:0009987 | cellular process | ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HCAR2, HMGCR, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TRPV1, TYR, XDH | 2.7666 |
[BP] GO:0010604 | positive regulation of macromolecule metabolic process | ADORA1, ADRA2A, ALOX15, AURKB, CDC25B, ESR1, ESR2, ESRRA, ESRRB, FLT3, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PDE5A, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, XDH | 2.76324 |
[BP] GO:0010038 | response to metal ion | ALOX15, CA2, CYP1A1, CYP1A2, FABP4, MAOB, MMP9, TERT | 2.74975 |
[BP] GO:0051239 | regulation of multicellular organismal process | ADORA1, ADORA3, ADRA2A, ALOX12, AXL, CA2, CYP1B1, ESR1, ESRRA, ESRRB, HCAR2, HMGCR, KCNH2, KDR, MET, MMP12, MMP9, PDE5A, PIM1, SLC6A4, SRC, TERT, TRPV1, XDH | 2.7478 |
[BP] GO:0060065 | uterus development | CYP19A1, ESR1, SRC | 2.72758 |
[BP] GO:0010562 | positive regulation of phosphorus metabolic process | ADORA1, ADRA2A, ALOX15, CDC25B, ESRRB, FABP3, FLT3, HMGCR, KDR, MMP9, PDE5A, PTPN1, SRC, XDH | 2.6254 |
[BP] GO:0045937 | positive regulation of phosphate metabolic process | ADORA1, ADRA2A, ALOX15, CDC25B, ESRRB, FABP3, FLT3, HMGCR, KDR, MMP9, PDE5A, PTPN1, SRC, XDH | 2.6254 |
[BP] GO:0044283 | None | AKR1B1, ALOX12, ALOX15, ALOX5, CES1, CYP19A1, CYP1A1, CYP3A4, HMGCR | 2.6254 |
[BP] GO:0022900 | electron transport chain | AKR1B1, AOX1, CYP19A1, CYP1A2, MAOB, XDH | 2.59245 |
[BP] GO:0051050 | positive regulation of transport | ACHE, ADORA1, ADRA2A, AXL, CA2, CYP19A1, HCAR2, KCNH2, MMP12, SLC6A4, SRC, TERT, TRPV1 | 2.58296 |
[BP] GO:2000145 | regulation of cell motility | ADORA1, ADORA3, ADRA2A, ALOX12, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, SRC, TERT | 2.57747 |
[BP] GO:0043405 | regulation of MAP kinase activity | ADORA1, ADRA2A, FLT3, HMGCR, IGF1R, PDE5A, PTPN1, SRC | 2.57747 |
[BP] GO:0030540 | female genitalia development | AXL, CYP19A1, ESR1 | 2.56944 |
[BP] GO:0019372 | lipoxygenase pathway | ALOX12, ALOX15, ALOX5 | 2.56944 |
[BP] GO:0010648 | negative regulation of cell communication | ACHE, ADORA1, ADRA2A, ESR1, ESR2, HMGCR, IGF1R, MET, MMP12, MMP9, PTPN1, SLC6A4, SRC, TERT, XDH | 2.54061 |
[BP] GO:1901361 | None | AOX1, CYP19A1, CYP1A1, CYP1A2, CYP2A6, CYP3A4, MAOB, PDE5A, XDH | 2.53141 |
[BP] GO:0023057 | negative regulation of signaling | ACHE, ADORA1, ADRA2A, ESR1, ESR2, HMGCR, IGF1R, MET, MMP12, MMP9, PTPN1, SLC6A4, SRC, TERT, XDH | 2.52994 |
[BP] GO:0048584 | positive regulation of response to stimulus | ADORA1, ADRA2A, AKR1B1, ALOX15, AXL, CYP1B1, ESRRA, FABP4, FLT3, HMGCR, KDR, MET, MMP12, MMP2, MMP9, PDE5A, PTPN1, SRC, TERT, XDH | 2.51191 |
[BP] GO:0080134 | regulation of response to stress | ADORA1, ADRA2A, ALOX12, CYP19A1, ESR1, FABP4, HMGCR, IGF1R, MET, MMP12, MMP2, PPARA, PTPN1, SRC, TERT, XDH | 2.50463 |
[BP] GO:0072593 | reactive oxygen species metabolic process | ALOX12, CYP1A1, CYP1A2, CYP1B1, MAOB | 2.49762 |
[BP] GO:0042327 | positive regulation of phosphorylation | ADORA1, ADRA2A, ALOX15, CDC25B, ESRRB, FLT3, HMGCR, KDR, MMP9, PDE5A, PTPN1, SRC, XDH | 2.49762 |
[BP] GO:1902531 | regulation of intracellular signal transduction | ADORA1, ADRA2A, AKR1B1, ALOX15, AURKB, AXL, CYP1B1, ESR1, FLT3, HMGCR, IGF1R, KDR, MET, MMP9, PDE5A, PTPN1, SRC, XDH | 2.48716 |
[BP] GO:0001666 | response to hypoxia | ADORA1, CYP1A1, MMP2, PPARA, SLC6A4, SRC, TERT | 2.45988 |
[BP] GO:0043408 | regulation of MAPK cascade | ADORA1, ADRA2A, ALOX15, FLT3, HMGCR, IGF1R, KDR, PDE5A, PTPN1, SRC, XDH | 2.45143 |
[BP] GO:0050994 | None | ADORA1, ADRA2A, HCAR2, PPARA | 2.44627 |
[BP] GO:0009628 | response to abiotic stimulus | ADORA1, AKR1B1, AURKB, CA2, CYP1A1, HMGCR, MMP2, PPARA, SLC6A4, SRC, TERT, TRPV1, TYR | 2.44615 |
[BP] GO:0044236 | multicellular organism metabolic process | MMP1, MMP12, MMP2, MMP9, TRPV1 | 2.43313 |
[BP] GO:0044092 | negative regulation of molecular function | ADORA3, ADRA2A, AURKB, CYP1B1, ESR1, FABP4, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC | 2.41079 |
[BP] GO:0034614 | cellular response to reactive oxygen species | AKR1B1, AXL, CYP1B1, MMP9, SRC | 2.41079 |
[BP] GO:0046110 | None | AOX1, XDH | 2.41079 |
[BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.41079 |
[BP] GO:0036293 | response to decreased oxygen levels | ADORA1, CYP1A1, MMP2, PPARA, SLC6A4, SRC, TERT | 2.41058 |
[BP] GO:0042325 | regulation of phosphorylation | ADORA1, ADRA2A, ALOX15, CDC25B, ESRRB, FABP4, FLT3, HMGCR, IGF1R, KDR, MMP9, PDE5A, PPARA, PTPN1, SRC, XDH | 2.40372 |
[BP] GO:0051046 | None | ACHE, ADORA1, ADRA2A, CYP19A1, HCAR2, HMGCR, MAOB, MMP12, SLC6A4, SRC, TRPV1 | 2.40327 |
[BP] GO:0018108 | peptidyl-tyrosine phosphorylation | AXL, FLT3, IGF1R, KDR, MET, SRC | 2.34204 |
[BP] GO:0040012 | regulation of locomotion | ADORA1, ADORA3, ADRA2A, ALOX12, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, SRC, TERT | 2.32517 |
[BP] GO:0051270 | regulation of cellular component movement | ADORA1, ADORA3, ADRA2A, ALOX12, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, SRC, TERT | 2.31321 |
[BP] GO:0018212 | peptidyl-tyrosine modification | AXL, FLT3, IGF1R, KDR, MET, SRC | 2.31194 |
[BP] GO:0044248 | cellular catabolic process | ACHE, AKR1B10, AOX1, AURKB, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP3A4, FABP3, FABP4, MAOB, PDE5A, SRC, XDH | 2.30988 |
[BP] GO:0051047 | None | ACHE, ADORA1, CYP19A1, HCAR2, MMP12, SLC6A4, SRC, TRPV1 | 2.30988 |
[BP] GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC | 2.29513 |
[BP] GO:0048871 | multicellular organismal homeostasis | ADORA1, AKR1B1, ALOX12, MET, TRPV1 | 2.26107 |
[BP] GO:1901575 | None | ACHE, ADORA1, AKR1B10, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, MAOB, PDE5A, XDH | 2.25588 |
[BP] GO:0019220 | regulation of phosphate metabolic process | ADORA1, ADRA2A, ALOX15, CDC25B, ESRRB, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, MMP9, PDE5A, PPARA, PTPN1, SRC, XDH | 2.24214 |
[BP] GO:0046777 | protein autophosphorylation | AURKB, FLT3, IGF1R, KDR, PIM1, SRC | 2.24214 |
[BP] GO:1904707 | positive regulation of vascular smooth muscle cell proliferation | MMP2, MMP9, TERT | 2.24214 |
[BP] GO:0030520 | intracellular estrogen receptor signaling pathway | ESR1, ESR2, SRC | 2.24214 |
[BP] GO:0050995 | None | ADORA1, ADRA2A, HCAR2 | 2.24214 |
[BP] GO:0070482 | response to oxygen levels | ADORA1, CYP1A1, MMP2, PPARA, SLC6A4, SRC, TERT | 2.21656 |
[BP] GO:0051174 | regulation of phosphorus metabolic process | ADORA1, ADRA2A, ALOX15, CDC25B, ESRRB, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, MMP9, PDE5A, PPARA, PTPN1, SRC, XDH | 2.21042 |
[BP] GO:0009404 | toxin metabolic process | CYP1A1, CYP1A2, CYP1B1 | 2.18858 |
[BP] GO:0006145 | None | AOX1, XDH | 2.17347 |
[BP] GO:0032847 | regulation of cellular pH reduction | CA2, CA7 | 2.17347 |
[BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.17347 |
[BP] GO:0043393 | regulation of protein binding | AURKB, MET, MMP9, PPARA, SRC, TERT | 2.16082 |
[BP] GO:0030574 | collagen catabolic process | MMP1, MMP12, MMP2, MMP9 | 2.15716 |
[BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B2 | 2.15322 |
[BP] GO:0048660 | regulation of smooth muscle cell proliferation | AKR1B1, HMGCR, MMP2, MMP9, TERT | 2.13843 |
[BP] GO:0048878 | chemical homeostasis | ADRA2A, AKR1B1, ALOX12, CA12, CA2, CA7, ESR1, FABP3, FABP4, KCNH2, MET, TRPV1 | 2.13843 |
[BP] GO:2000021 | regulation of ion homeostasis | ADORA1, CA2, CA7, KDR, SRC, TRPV1 | 2.13744 |
[BP] GO:0001934 | positive regulation of protein phosphorylation | ADORA1, ADRA2A, ALOX15, CDC25B, FLT3, HMGCR, KDR, MMP9, PDE5A, PTPN1, SRC, XDH | 2.13346 |
[BP] GO:0042180 | None | AKR1B1, AKR1B10, CYP19A1, HMGCR | 2.07063 |
[BP] GO:0006706 | steroid catabolic process | CYP19A1, CYP1A2, CYP3A4 | 2.06162 |
[BP] GO:0048856 | anatomical structure development | ACHE, ADORA1, AKR1B1, ALOX15, AXL, CA2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, MAOB, MMP9, PIM1, PPARA, RORC, SRC, TYR | 2.05369 |
[BP] GO:1903530 | regulation of secretion by cell | ACHE, ADORA1, ADRA2A, CYP19A1, HCAR2, HMGCR, MAOB, MMP12, SLC6A4, SRC | 2.03297 |
[BP] GO:0071495 | cellular response to endogenous stimulus | ADRA2A, AKR1B1, ESR1, FLT3, IGF1R, MMP2, NR3C1, SLC6A4, SRC, TRPV1 | 2.02957 |
[CC] GO:0044432 | endoplasmic reticulum part | CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, FLT3, HMGCR, HSD11B1, HSD17B2, PTPN1 | 2.52067 |
[CC] GO:0044444 | cytoplasmic part | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, AURKB, CA1, CA2, CA4, CA5A, CA5B, CA7, CDC25B, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, ESR1, ESR2, FABP3, FABP4, FLT3, HMGCR, HSD11B1, HSD17B2, KCNH2, KDR, MAOB, MMP2, MMP9, NR3C1, PDE5A, PIM1, PTPN1, SLC6A4, SRC, TERT, TRPV1, TYR, XDH | 2.41079 |
[CC] GO:0097443 | sorting endosome | KDR, PTPN1 | 1.8589 |
[CC] GO:0005789 | endoplasmic reticulum membrane | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, HMGCR, HSD11B1, HSD17B2 | 1.70261 |
[CC] GO:0016020 | membrane | ACHE, ADORA1, ADORA3, ADRA2A, ALOX12, ALOX15, ALOX5, AXL, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, ESR1, FLT3, HCAR2, HMGCR, HSD11B1, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MET, MMP2, PIM1, PTPN1, SLC6A2, SLC6A4, SRC, TERT, TRPV1, TYR | 1.59495 |
[MF] GO:0046914 | transition metal ion binding | ALOX12, ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, RORC, TYR, XDH | 23.0842 |
[MF] GO:0004089 | carbonate dehydratase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 17.4654 |
[MF] GO:0043167 | ion binding | ACHE, ALOX12, ALOX15, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TRPV1, TYR, XDH | 12.4537 |
[MF] GO:0016836 | hydro-lyase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 11.0089 |
[MF] GO:0043169 | cation binding | ACHE, ALOX12, ALOX15, ALOX5, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NR3C1, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TRPV1, TYR, XDH | 10.8136 |
[MF] GO:0005506 | iron ion binding | ALOX12, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, XDH | 10.8136 |
[MF] GO:0003824 | catalytic activity | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, FLT3, HMGCR, HSD11B1, HSD17B2, IGF1R, KCNH2, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PTPN1, SRC, TERT, TYR, XDH | 10.8136 |
[MF] GO:0046872 | metal ion binding | ALOX12, ALOX15, ALOX5, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NR3C1, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TRPV1, TYR, XDH | 10.4347 |
[MF] GO:0016835 | carbon-oxygen lyase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 9.90622 |
[MF] GO:0008270 | zinc ion binding | CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NR3C1, PPARA, PTPN1, RORC | 9.66963 |
[MF] GO:0016491 | oxidoreductase activity | AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, HMGCR, HSD11B1, HSD17B2, MAOB, TYR, XDH | 9.53068 |
[MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4 | 8.59536 |
[MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, TYR | 7.55075 |
[MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 | 7.08225 |
[MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP3A4 | 6.98794 |
[MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, SRC | 6.54362 |
[MF] GO:0016829 | lyase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 6.4469 |
[MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, SRC | 6.27421 |
[MF] GO:0003707 | steroid hormone receptor activity | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC | 6.20944 |
[MF] GO:0008395 | steroid hydroxylase activity | CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2C19, CYP3A4 | 6.10614 |
[MF] GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, TYR | 5.90608 |
[MF] GO:0048037 | cofactor binding | AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP3A4, HMGCR, MAOB, SRC, XDH | 5.48731 |
[MF] GO:0098531 | transcription factor activity, direct ligand regulated sequence-specific DNA binding | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC | 5.251 |
[MF] GO:0004879 | nuclear receptor activity | ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC | 5.251 |
[MF] GO:0005496 | steroid binding | CYP3A4, ESR1, ESR2, ESRRA, ESRRB, NR3C1, RORC | 5.23695 |
[MF] GO:0008289 | lipid binding | ALOX15, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, NR3C1, PPARA, RORC, TRPV1 | 3.99448 |
[MF] GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | AKR1B1, AKR1B10, AOX1, HMGCR, HSD11B1, HSD17B2, XDH | 3.99448 |
[MF] GO:0038023 | signaling receptor activity | ADORA1, ADORA3, ADRA2A, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, HCAR2, IGF1R, KCNH2, KDR, MET, NR3C1, PPARA, RORC, TRPV1 | 3.89983 |
[MF] GO:0009055 | electron transfer activity | AKR1B1, AOX1, CYP19A1, CYP1A2, MAOB, XDH | 3.44306 |
[MF] GO:0004714 | transmembrane receptor protein tyrosine kinase activity | AXL, FLT3, IGF1R, KDR, MET | 3.3753 |
[MF] GO:0032403 | protein complex binding | ACHE, ADORA1, ADRA2A, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC | 3.35141 |
[MF] GO:0004872 | receptor activity | ADORA1, ADORA3, ADRA2A, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, HCAR2, IGF1R, KCNH2, KDR, MET, NR3C1, PPARA, RORC, TRPV1 | 3.27116 |
[MF] GO:0008144 | drug binding | ACHE, AURKB, AXL, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP3A4, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SLC6A4, SRC, TRPV1 | 3.2531 |
[MF] GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups | CYP1A2, CYP3A4, XDH | 3.2531 |
[MF] GO:0060089 | molecular transducer activity | ADORA1, ADORA3, ADRA2A, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, HCAR2, IGF1R, KCNH2, KDR, MET, NR3C1, PPARA, RORC, TRPV1 | 3.10154 |
[MF] GO:0044877 | macromolecular complex binding | ACHE, ADORA1, ADRA2A, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A4, SRC | 3.072 |
[MF] GO:0042802 | identical protein binding | ACHE, ADRA2A, AOX1, ESR1, ESR2, FLT3, HMGCR, IGF1R, KCNH2, KDR, MAOB, MET, MMP9, SLC6A4, TERT, TRPV1, TYR, XDH | 3.02083 |
[MF] GO:0019199 | transmembrane receptor protein kinase activity | AXL, FLT3, IGF1R, KDR, MET | 2.92946 |
[MF] GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding | ESR1, ESR2 | 2.78037 |
[MF] GO:0047977 | hepoxilin-epoxide hydrolase activity | ALOX12, ALOX15 | 2.78037 |
[MF] GO:0008389 | None | CYP2A13, CYP2A6 | 2.78037 |
[MF] GO:0004871 | signal transducer activity | ADORA1, ADORA3, ADRA2A, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, HCAR2, IGF1R, KCNH2, KDR, MET, NR3C1, PPARA, RORC, TRPV1 | 2.77603 |
[MF] GO:0016903 | None | AKR1B1, AKR1B10, AOX1, XDH | 2.67813 |
[MF] GO:0008392 | None | CYP2A13, CYP2A6, CYP2C19 | 2.50463 |
[MF] GO:0008391 | None | CYP2A13, CYP2A6, CYP2C19 | 2.50463 |
[MF] GO:0070576 | vitamin D 24-hydroxylase activity | CYP1A1, CYP3A4 | 2.41079 |
[MF] GO:0004052 | arachidonate 12-lipoxygenase activity | ALOX12, ALOX15 | 2.41079 |
[MF] GO:0005330 | None | SLC6A2, SLC6A4 | 2.41079 |
[MF] GO:0051120 | hepoxilin A3 synthase activity | ALOX12, ALOX15 | 2.41079 |
[MF] GO:0047374 | None | CES1, CES2 | 2.41079 |
[MF] GO:0004713 | protein tyrosine kinase activity | AXL, FLT3, IGF1R, KDR, MET, SRC | 2.40372 |
[MF] GO:0001223 | transcription coactivator binding | ESR1, PPARA, TERT | 2.3411 |
[MF] GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | AKR1B1, AKR1B10, HMGCR, HSD11B1, HSD17B2 | 2.24776 |
[MF] GO:0034056 | estrogen response element binding | ESR1, ESR2 | 2.17347 |
[MF] GO:0034875 | caffeine oxidase activity | CYP1A2, CYP3A4 | 2.17347 |
[MF] GO:0032795 | None | ADORA1, ADRA2A | 2.17347 |
[MF] GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | CYP1A2, CYP3A4 | 2.17347 |
[MF] GO:0042803 | protein homodimerization activity | ACHE, ADRA2A, AOX1, FLT3, HMGCR, KCNH2, MAOB, SLC6A4, TERT, TYR, XDH | 2.15506 |
[MF] GO:0019899 | enzyme binding | ADRA2A, AURKB, CDC25B, CYP1A1, CYP1A2, CYP2A6, CYP2C19, CYP3A4, ESR1, ESR2, ESRRB, HMGCR, KCNH2, MET, NR3C1, PPARA, PTPN1, SLC6A4, SRC | 2.08162 |
[MF] GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | ALOX12, ALOX15, ALOX5 | 2.06162 |
[MF] GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | ALOX12, ALOX15, ALOX5 | 2.01886 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA1, CA5B, CA5A, CA2, CA4, CA7, CA6, CA9, CA14 | 18.776 |
Chemical carcinogenesis_Homo sapiens_hsa05204 | HSD11B1, CYP2A6, CYP2A13, CYP1A2, CYP1A1, CYP1B1, CYP3A4, CYP2C19 | 7.8069 |
Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD11B1, HSD17B2, CYP1A2, CYP1A1, CYP1B1, CYP3A4, CYP19A1 | 7.501 |
Metabolic pathways_Homo sapiens_hsa01100 | MAOB, ALOX15, AKR1B1, ALOX12, HMGCR, TYR, CYP3A4, CYP2C19, CYP19A1, HSD11B1, CYP2A6, AKR1B10, ALOX5, HSD17B2, CYP1A2, CYP1A1, AOX1, XDH, CES1 | 6.6167 |
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | HSD11B1, CYP2A6, CYP2A13, CYP1A2, CYP1A1, CYP1B1, CYP3A4 | 6.909 |
Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, HSD17B2, CYP1A1, CYP1B1, CYP19A1, IGF1R | 6.5482 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | CYP2A6, MAOB, CYP1A2, AOX1, CYP3A4, CYP2C19 | 5.7587 |
Tryptophan metabolism_Homo sapiens_hsa00380 | MAOB, CYP1A2, CYP1A1, AOX1, CYP1B1 | 5.5299 |
Serotonergic synapse_Homo sapiens_hsa04726 | MAOB, ALOX5, ALOX15, ALOX12, CYP2C19, SLC6A4 | 4.7031 |
Drug metabolism - other enzymes_Homo sapiens_hsa00983 | CYP2A6, CYP3A4, XDH, CES2, CES1 | 5.3147 |
Proteoglycans in cancer_Homo sapiens_hsa05205 | SRC, MMP2, KDR, MMP9, MET, ESR1, IGF1R | 4.4064 |
Retinol metabolism_Homo sapiens_hsa00830 | CYP2A6, CYP1A2, CYP1A1, AOX1, CYP3A4 | 4.6629 |
Estrogen signaling pathway_Homo sapiens_hsa04915 | SRC, MMP2, MMP9, ESR1, ESR2 | 3.8598 |
Bladder cancer_Homo sapiens_hsa05219 | SRC, MMP1, MMP2, MMP9 | 4.1083 |
Arachidonic acid metabolism_Homo sapiens_hsa00590 | ALOX5, ALOX15, ALOX12, CYP2C19 | 3.4442 |
Linoleic acid metabolism_Homo sapiens_hsa00591 | ALOX15, CYP1A2, CYP3A4, CYP2C19 | 4.6629 |
Adherens junction_Homo sapiens_hsa04520 | PTPN1, SRC, MET, IGF1R | 3.191 |
PPAR signaling pathway_Homo sapiens_hsa03320 | FABP3, FABP4, MMP1, PPARA | 3.2863 |
Pathways in cancer_Homo sapiens_hsa05200 | FLT3, MMP1, MMP2, MMP9, MET, IGF1R | 2.0009 |
Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | ADORA3, ADORA1, TRPV1, NR3C1, ADRA2A | 1.9755 |
Prolactin signaling pathway_Homo sapiens_hsa04917 | SRC, ESR1, ESR2 | 2.0337 |
cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | ADORA3, ADORA1, PDE5A, ADRA2A | 1.9755 |
MicroRNAs in cancer_Homo sapiens_hsa05206 | PIM1, CYP1B1, MMP9, MET, CDC25B | 1.9048 |
Bile secretion_Homo sapiens_hsa04976 | CA2, HMGCR, CYP3A4 | 2.0337 |
Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | FLT3, MMP9, MET, IGF1R | 1.9048 |
Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | SRC, ALOX12, TRPV1 | 1.7734 |
Tyrosine metabolism_Homo sapiens_hsa00350 | MAOB, AOX1, TYR | 2.914 |
Focal adhesion_Homo sapiens_hsa04510 | SRC, KDR, MET, IGF1R | 1.7731 |
Rap1 signaling pathway_Homo sapiens_hsa04015 | SRC, KDR, MET, IGF1R | 1.7335 |
Endocytosis_Homo sapiens_hsa04144 | SRC, KDR, MET, IGF1R | 1.4516 |
cAMP signaling pathway_Homo sapiens_hsa04024 | HCAR2, ADORA1, PPARA | 1.1365 |
Ras signaling pathway_Homo sapiens_hsa04014 | KDR, MET, IGF1R | 1.011 |
Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, ADORA1 | 1.3199 |
Acute myeloid leukemia_Homo sapiens_hsa05221 | FLT3, PIM1 | 1.3172 |
VEGF signaling pathway_Homo sapiens_hsa04370 | SRC, KDR | 1.2843 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | MMP2, PIM1 | 0.9792 |
GnRH signaling pathway_Homo sapiens_hsa04912 | SRC, MMP2 | 1.0336 |
Melanoma_Homo sapiens_hsa05218 | MET, IGF1R | 1.203 |
Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | CDC25B, IGF1R | 0.9935 |
Central carbon metabolism in cancer_Homo sapiens_hsa05230 | FLT3, MET | 1.2294 |
Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | FLT3, KDR, MET | 0.901 |
Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B10, AKR1B1 | 1.3004 |
Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | SRC, MET | 1.2278 |
Insulin resistance_Homo sapiens_hsa04931 | PTPN1, PPARA | 0.9285 |
Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | SRC, MET | 1.1372 |
Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | SRC, ESR1 | 0.901 |
Leukocyte transendothelial migration_Homo sapiens_hsa04670 | MMP2, MMP9 | 0.901 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 | ADORA3, ADORA1 | 0.8959 |
Hepatitis B_Homo sapiens_hsa05161 | SRC, MMP9 | 0.7862 |
AMPK signaling pathway_Homo sapiens_hsa04152 | HMGCR, IGF1R | 0.8788 |
Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | ESRRB, IGF1R | 0.7994 |
PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | KDR, MET, IGF1R | 0.7324 |
Jak-STAT signaling pathway_Homo sapiens_hsa04630 | PIM1, AOX1 | 0.756 |
Purine metabolism_Homo sapiens_hsa00230 | PDE5A, XDH | 0.6914 |
Galactose metabolism_Homo sapiens_hsa00052 | AKR1B10, AKR1B1 | 1.7731 |
MAPK signaling pathway_Homo sapiens_hsa04010 | CDC25B | 0.2395 |
HTLV-I infection_Homo sapiens_hsa05166 | TERT | 0.2395 |
Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | SRC | 0.2858 |
Viral carcinogenesis_Homo sapiens_hsa05203 | SRC | 0.2951 |
Alcoholism_Homo sapiens_hsa05034 | MAOB | 0.3297 |
Tuberculosis_Homo sapiens_hsa05152 | SRC | 0.3297 |
Chemokine signaling pathway_Homo sapiens_hsa04062 | SRC | 0.3197 |
Platelet activation_Homo sapiens_hsa04611 | SRC | 0.4126 |
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | PPARA | 0.3737 |
ErbB signaling pathway_Homo sapiens_hsa04012 | SRC | 0.4706 |
Oxytocin signaling pathway_Homo sapiens_hsa04921 | SRC | 0.3625 |
TNF signaling pathway_Homo sapiens_hsa04668 | MMP9 | 0.4347 |
Insulin signaling pathway_Homo sapiens_hsa04910 | PTPN1 | 0.3977 |
Cholinergic synapse_Homo sapiens_hsa04725 | ACHE | 0.4347 |
Oocyte meiosis_Homo sapiens_hsa04114 | IGF1R | 0.4126 |
FoxO signaling pathway_Homo sapiens_hsa04068 | IGF1R | 0.4048 |
Tight junction_Homo sapiens_hsa04530 | SRC | 0.3977 |
Melanogenesis_Homo sapiens_hsa04916 | TYR | 0.4556 |
Hepatitis C_Homo sapiens_hsa05160 | PPARA | 0.4048 |
HIF-1 signaling pathway_Homo sapiens_hsa04066 | IGF1R | 0.453 |
Cell cycle_Homo sapiens_hsa04110 | CDC25B | 0.4126 |
Toxoplasmosis_Homo sapiens_hsa05145 | ALOX5 | 0.4173 |
Glucagon signaling pathway_Homo sapiens_hsa04922 | PPARA | 0.4556 |
Axon guidance_Homo sapiens_hsa04360 | MET | 0.4085 |
Dopaminergic synapse_Homo sapiens_hsa04728 | MAOB | 0.4073 |
Prostate cancer_Homo sapiens_hsa05215 | IGF1R | 0.4706 |
Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | IGF1R | 0.465 |
GABAergic synapse_Homo sapiens_hsa04727 | SRC | 0.4706 |
Morphine addiction_Homo sapiens_hsa05032 | ADORA1 | 0.4706 |
Gap junction_Homo sapiens_hsa04540 | SRC | 0.4706 |
Hematopoietic cell lineage_Homo sapiens_hsa04640 | FLT3 | 0.4706 |
Rheumatoid arthritis_Homo sapiens_hsa05323 | MMP1 | 0.4706 |
Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.465 |
Pancreatic secretion_Homo sapiens_hsa04972 | CA2 | 0.465 |
Peroxisome_Homo sapiens_hsa04146 | XDH | 0.4706 |
Gastric acid secretion_Homo sapiens_hsa04971 | CA2 | 0.5085 |
Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | IGF1R | 0.537 |
Glioma_Homo sapiens_hsa05214 | IGF1R | 0.537 |
Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B10, AKR1B1 | 1.6649 |
Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.5246 |
Long-term depression_Homo sapiens_hsa04730 | IGF1R | 0.5396 |
Renal cell carcinoma_Homo sapiens_hsa05211 | MET | 0.5366 |
Renin secretion_Homo sapiens_hsa04924 | ADORA1 | 0.537 |
Amphetamine addiction_Homo sapiens_hsa05031 | MAOB | 0.5361 |
Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | RORC | 0.537 |
Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B10, AKR1B1 | 1.7387 |
Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 1.9326 |
Shigellosis_Homo sapiens_hsa05131 | SRC | 0.537 |
Malaria_Homo sapiens_hsa05144 | MET | 0.6078 |
Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | ESR1 | 0.6078 |
Cocaine addiction_Homo sapiens_hsa05030 | MAOB | 0.6078 |
Arginine and proline metabolism_Homo sapiens_hsa00330 | MAOB | 0.6059 |
Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | AOX1 | 0.6078 |
Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | MAOB | 0.6645 |
Caffeine metabolism_Homo sapiens_hsa00232 | CYP2A6, CYP1A2, XDH | 5.3525 |
Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | AOX1 | 0.763 |
Circadian rhythm_Homo sapiens_hsa04710 | RORC | 0.756 |
Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.7854 |
Histidine metabolism_Homo sapiens_hsa00340 | MAOB | 0.8128 |
Phenylalanine metabolism_Homo sapiens_hsa00360 | MAOB | 0.9017 |
Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | HMGCR | 0.8416 |
Vitamin B6 metabolism_Homo sapiens_hsa00750 | AOX1 | 1.2407 |